Levin, Andrew E.
- Kephera Diagnostics, LLC (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #945
- Rising Star
- Top 5% Funded
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$4.4M
Full award amounts, FY2023
Award Records
5
Records listing this PI
Award-Linked Rank
#945
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Levin, Andrew E. as a PI. Multi-PI records show the full award amount for context.
- 2R44AI142903-03A1R44Contact PIHybrid ELISA: Simple and specific one-tier assay for Lyme disease$1Maward amount
- 2R44AI136172-03A1R44Contact PIPoint-of-care diagnostic test for T. cruzi (Chagas) infection$1Maward amount
- $1Maward amount
- 2R44AI149903-03R44Contact PIRapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients$999Kaward amount
- 1R43AI174487-01A1R43Contact PIDevelopment of an ELISA for serosurveillance of human hookworm$300Kaward amount
Award organization
Organizations that administered FY2023 awards listing Levin, Andrew E. as a PI.
FY2023 award administered by Kephera Diagnostics, LLC (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardKephera Diagnostics, LLC
- 2006$500K Cumulative Funding
- 2006$1M Cumulative Funding
- 2006Entered Top 50% NationallyRanked #3791
- 2006Entered Top 25% NationallyRanked #3791
- 2007$2M Cumulative Funding
- 2010$5M Cumulative Funding
- 2013$10M Cumulative Funding
- 2013Entered Top 10% NationallyRanked #1678
- 2015Entered Top 5% NationallyRanked #657
- 2023$25M Cumulative Funding